List of insiders holdings for GENELUX Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Szalay Aladar 10% Owner | 2024-10-22 16:12:19 | 3,413,581 0 | 3,413,581 | Form 13G |
| Thomas John Director | 2024-08-05 18:35:55 | 555,970 0 | 555,970 | Form 4 |
| Zhang Qian Associate VP, Research | 2023-05-02 16:26:03 | 139,333 200 | 139,533 | Form 4 |
| Smither John W Director | 2024-08-05 18:34:58 | 103,180 0 | 103,180 | Form 4 |
| Mirabelli Mary Director | 2024-08-05 18:36:28 | 102,470 0 | 102,470 | Form 4 |
| Zindrick Thomas President and CEO | 2024-07-08 16:30:20 | 50,207 0 | 50,207 | Form 4 |
| Tyree James L Director | 2024-09-26 16:44:02 | 49,251 0 | 49,251 | Form 4/A |
| Samuelson Doug Vice President, Finance | 2023-09-12 16:25:20 | 40,000 0 | 40,000 | Form 4 |
| Zak Lourie S. Chief Financial Officer | 2024-07-08 16:30:18 | 38,428 0 | 38,428 | Form 4 |
| Scigalla Paul Chief Medical Officer | 2024-10-21 17:05:05 | 33,332 0 | 33,332 | Form 4 |
| Cappello Joseph VP, Pharmaceutical Development | 2024-07-08 16:30:14 | 20,953 0 | 20,953 | Form 4 |
| Ryder Sean General Counsel | 2024-07-08 16:30:11 | 19,388 0 | 19,388 | Form 4 |
| Smalling Ralph Head of Regulatory | 2024-07-08 16:30:16 | 18,144 0 | 18,144 | Form 4 |
| Jewett Caroline Head of Quality | 2024-07-08 16:30:09 | 16,174 0 | 16,174 | Form 4 |
| Woodward Gabe Director | 2023-05-02 16:30:22 | 4,186 8,176 | 12,362 | Form 4 |
| Yu Yong VP, Clinical Trial Operations | 2024-07-08 16:30:13 | 10,869 0 | 10,869 | Form 4 |